13774214275
13774214275
產(chǎn)品中心
當(dāng)前位置：首頁
產(chǎn)品中心抗體/抗原Biosimilar抗體S0B0437Bevacizumab
產(chǎn)品型號(hào)：S0B0437
更新時(shí)間：2025-08-09
廠商性質(zhì)：生產(chǎn)廠家
訪問量：68
服務(wù)熱線15855403091
產(chǎn)品分類
相關(guān)文章
Bevacizumab works by blocking a protein called VEGF, which some cancer cells produce in large amounts. Blocking VEGF may prevent the growth of new blood vessels that tumors need to grow. Bevacizumab is a type of targeted therapy called an angiogenesis inhibitor. For cancer, it is given by slow injection into a vein （intravenous） and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma. In many of these diseases it is used as a first-line therapy. For age-related macular degeneration it is given by injection into the eye （intravitreal）.
關(guān)于我們
公司簡(jiǎn)介 企業(yè)文化 榮譽(yù)資質(zhì)產(chǎn)品分類
抗體/抗原 蛋白新聞文章
新聞中心 技術(shù)文章聯(lián)系我們
聯(lián)系方式 在線留言 地圖導(dǎo)航15855403091
（全國服務(wù)熱線）浙江省杭州市上城區(qū)同協(xié)路1279號(hào)西子智慧產(chǎn)業(yè)園7號(hào)樓4層
關(guān)注公眾號(hào)
Copyright © 2025杭州斯達(dá)特生物科技有限公司 All Rights Reserved 工信部備案號(hào)：
技術(shù)支持：化工儀器網(wǎng) 管理登錄 sitemap.xml
上一個(gè)：
返回列表
